Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chromosome 2 open reading frame 72 (C2orf72) is a protein-coding gene in humans encoding an uncharacterized intracellular protein, also referred to as "uncharacterized protein C2orf72" or LOC257407. The precise molecular function of C2orf72 is currently unknown, but it is predicted—mainly from gene expression and computational analyses—to be involved in very-low-density lipoprotein (VLDL) particle assembly and in the regulation of cholesterol esterification. Expression of C2orf72 is seen predominantly in the liver, brain, placenta, small intestine, and colon, with the protein localized mainly to the cell membrane and cytoplasm, and possibly in the nucleus. Both estradiol and testosterone have been shown to upregulate C2orf72 expression, and its expression is reduced in the absence of hepatocyte nuclear factor 4 alpha (HNF4α). No established roles in disease, therapeutic targeting, or drug interaction are currently reported for C2orf72. It interacts with proteins NRas, KRas, and CD81, but the functional significance of these interactions is also uncharacterized.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromosome 2 open reading frame 72 (C2orf72).